With the continuous development of the pharmaceutical industry, the requirements for production efficiency, product quality, and compliance are becoming increasingly stringent. The traditional pharmaceutical production model is gradually unable to meet these high standards, and high-end and intelligent have become new directions for industry transformation and upgrading. Canaan Technology's oral solid dosage equipment and intelligent factory business have ushered in broad development space in this context. It can provide a one-stop solution for pharmaceutical companies from process design to whole line delivery, integrating digital platforms (such as MES system) to achieve full lifecycle management of production. Automated robots accurately complete weighing, granulation, tablet pressing and other processes, and intelligent logistics systems (AGV) seamlessly connect various production links, effectively eliminating pollution risks and helping pharmaceutical companies reduce costs, increase efficiency and upgrade compliance. This intelligent production mode not only improves production efficiency and reduces errors and pollution caused by manual intervention, but also monitors production data in real time to ensure the stability and batch consistency of product quality, complying with international standards such as FDA/GMP, greatly meeting the demand of pharmaceutical companies for high-end and intelligent production, and becoming an important driving force for company performance growth.

 

 

 

The scale of innovative drugs in the biotechnology industry continues to expand

 

 

 

The biopharmaceutical field has developed rapidly in recent years, with the research and production scale of innovative drugs constantly expanding. Canaan Technology, through its subsidiary Shanghai Kaixian, has laid out its business in the field of water equipment and liquid preparation systems for biological and sterile preparations. This business segment has seized the opportunity of rapid development in the biopharmaceutical industry. In the process of biopharmaceuticals, the quality and stability of pharmaceutical water equipment and dispensing systems are directly related to the safety and effectiveness of drugs. Shanghai Kaixian has mastered the core technology of biopharmaceutical water systems, possessing core capabilities in the entire process from primary/secondary design, 3D design and dynamic simulation, to module manufacturing and construction, self-control programming, computer debugging and verification, and after-sales maintenance. It can provide professional fluid system comprehensive solutions for the biopharmaceutical and pharmaceutical industries, thus gaining a share in the development wave of the biopharmaceutical industry and bringing significant performance growth to the company.

 

 

 

The smart logistics and specialized robot industry is flourishing

 

 

 

In the context of Industry 4.0, the application of smart logistics and specialized robot technology is becoming increasingly widespread in various industries, including the pharmaceutical industry. Canaan Technology's intelligent warehousing and logistics system business and specialized robot business can create an intelligent warehousing and logistics system for pharmaceutical companies, achieve precise storage, handling, and distribution of materials, improve warehouse space utilization, and reduce logistics costs and error rates. For example, its four-way shuttle robot and autonomous mobile robot have been applied in pharmaceutical companies, continuously optimizing product systems and expanding application scenarios. These intelligent devices can be closely integrated with the pharmaceutical production process, enhancing the overall level of intelligent production and operation, conforming to the trend of industry development, and injecting new vitality into the company's performance growth.

 

 

 

Domestic industrial upgrading, increased industry concentration, and import substitution demand bring growth potential

 

 

 

From the perspective of the domestic market, on the one hand, with the upgrading of the domestic pharmaceutical industry, many pharmaceutical companies have increased their investment in technological transformation and equipment updates to enhance their competitiveness. Canaan Technology, with its years of technological accumulation and innovation capabilities in the field of pharmaceutical equipment, can provide high-end products and solutions that meet the needs of industrial upgrading, meeting the urgent demand of pharmaceutical companies for advanced equipment.

 

 

 

On the other hand, the increase in industry concentration has made the dominant position of large pharmaceutical companies in the market increasingly apparent. When expanding production capacity and building new factories, they tend to choose suppliers who can provide one-stop services, have reliable product quality, and have technological advantages. Canaan Technology's extensive customer resources (covering all regions in China except Taiwan, China and Macao) and full industrial chain service capabilities give it significant advantages in cooperation with large pharmaceutical enterprises.

 

 

 

In addition, the domestic high-end pharmaceutical equipment market has long been dominated by foreign manufacturers, and some of Canaan Technology's products have reached the international advanced level, with quality and performance similar to advanced foreign products, and prices far lower than imported equipment. It has the strength of import substitution and can meet the demand of domestic pharmaceutical companies for high-end products while reducing procurement costs, thus achieving rapid growth in the market space of import substitution.

 

 

 

Export opportunities brought by technological innovation in the international market

 

 

 

In the international market, Canaan Technology has continuously improved the technological content and added value of its products through continuous technological innovation, enhancing their competitiveness in the international market. The company currently has clients in over 50 countries worldwide, and many internationally renowned pharmaceutical companies such as Sanofi and Novartis are its long-term partners. With the continuous increase of the company's R&D investment (reaching 80.7557 million yuan in 2024), its products have made many breakthroughs in technological innovation, such as reaching international high levels in key technical indicators such as automation, intelligence, and informatization of intelligent pharmaceutical equipment. These technological innovations enable the company to launch more high-end products that meet international market demands, further expand its international market share, obtain more opportunities for high-end product exports, and open up growth space in the international market.

 

 

 

Business opportunities arising from the rapid development of biopharmaceutical and robotics industries

 

 

 

In the field of biopharmaceuticals, the continuous research and development of innovative drugs and the expansion of production scale have led to an explosive growth in demand for water equipment and liquid preparation system engineering for biological and sterile preparations. Canaan Technology's technological advantages and market layout in this field enable it to fully benefit from the development trend of this industry.

 

 

 

In the robotics industry, as pharmaceutical companies' demand for intelligent production continues to increase, there is also a growing demand for the application of specialized robots in material handling, production operations, and other aspects. Canaan Technology is actively expanding its robot business, conducting product research and innovation to meet the special needs of pharmaceutical companies, optimizing its product system, and continuously expanding the application scenarios of robots in the pharmaceutical industry, in order to explore more business opportunities in these two rapidly developing industries and achieve sustained growth in performance.

 

 

 

conclusion

 

 

 

Canaan Technology has sufficient orders on hand, which basically meets the current production needs and provides a solid guarantee for performance growth. In the face of the future, the industry believes that companies should continue to increase investment in research and development, maintain a position in technological innovation, continuously optimize products and services in existing business segments, improve product quality and performance, in order to better meet market demand. In terms of market expansion, we will further cultivate the domestic market, seize the opportunities of industrial upgrading and increasing industry concentration, and strengthen the depth and breadth of cooperation with large domestic pharmaceutical companies; At the same time, actively exploring international markets and leveraging the product advantages brought by technological innovation to increase international market share. In addition, we will continue to monitor the development trends of the biopharmaceutical and robotics industries, adjust our business strategies in a timely manner, fully explore new business opportunities, ensure that the company maintains a leading position in the pharmaceutical equipment industry competition, achieve sustainable performance growth, and create greater value for investors.